Head-To-Head Analysis: Boxlight (NASDAQ:BOXL) & Mymd Pharmaceuticals (NASDAQ:QCLS)

Boxlight (NASDAQ:BOXL) and Mymd Pharmaceuticals (NASDAQ:QCLS) are both small-cap technology companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, dividends, institutional ownership, risk, valuation, analyst recommendations and earnings.

Profitability

This table compares Boxlight and Mymd Pharmaceuticals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Boxlight	-20.96%	N/A	-22.79%
Mymd Pharmaceuticals	N/A	-91.64%	-47.48%

Analyst Recommendations

This is a summary of recent recommendations and price targets for Boxlight and Mymd Pharmaceuticals, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Boxlight	1	0	0	0	1.00
Mymd Pharmaceuticals	1	0	0	0	1.00

Risk and Volatility

Boxlight has a beta of 0.81, suggesting that its share price is 19% less volatile than the S&P 500. Comparatively, Mymd Pharmaceuticals has a beta of 2.16, suggesting that its share price is 116% more volatile than the S&P 500.

Earnings & Valuation

This table compares Boxlight and Mymd Pharmaceuticals”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Boxlight	$109.25 million	0.04	-$23.81 million	($136.29)	-0.05
Mymd Pharmaceuticals	N/A	N/A	-$11.63 million	($20.69)	-0.13

Mymd Pharmaceuticals has lower revenue, but higher earnings than Boxlight. Mymd Pharmaceuticals is trading at a lower price-to-earnings ratio than Boxlight, indicating that it is currently the more affordable of the two stocks.

Institutional and Insider Ownership

6.5% of Boxlight shares are owned by institutional investors. Comparatively, 9.6% of Mymd Pharmaceuticals shares are owned by institutional investors. 15.4% of Boxlight shares are owned by company insiders. Comparatively, 0.9% of Mymd Pharmaceuticals shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

About Boxlight

Boxlight Corporation designs, produces, and distributes interactive technology solutions for the education, health, corporate, military, and government sectors in the Americas, Europe, the Middle East, Africa, and internationally. The company provides interactive and non-interactive flat panel displays and whiteboards, LED video walls, digital signages, classroom audio and campus communication, cameras and other peripherals, and media players; and accessory document cameras, teacher pads for remote control, assessment systems, and front-of-class display products under the Mimio and Clevertouch brands. It also offers MimioStudio Interactive Instructional software that enables the creation, editing, and presentation of interactive instructional lessons and activities; MimioMobile, a software accessory for MimioStudio; Oktopus Instructional and Whiteboarding software, which enables the creation, editing, and presentation of interactive instructional lessons and activities; Notes+, a software accessory; GameZones, a multi-student interactive gaming software; MimioConnect, an online student engagement platform; and LYNX, a lesson building app. In addition, the company provides Juno, a towering standard of sound quality that reinforces a teacher's voice; Mimio MyBot system for robotics learning; Robo3D printers; MyStemKits, which offers lesson plans for grades K-12 math and science teachers; MimioView document camera; EzRoom, an integrated AV solution; Lyrik, an amplification solution; and Conductor School Communication System, an IP-based campus-wide communication and control solution; and accessories, such as mobile carts, installation accessories, and wall-mount accessories for interactive LED flat-panels and audio solutions. Further, it offers classroom training, professional development, and educator certification services. The company was formerly known as Logical Choice Corporation. Boxlight Corporation was founded in 1985 and is headquartered in Duluth, Georgia.

About Mymd Pharmaceuticals

TNF Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on developing two novel therapeutic platforms that treat the causes of disease rather than addressing the symptoms. Its MYMD-1 is a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other pro-inflammatory cell signaling cytokines. The MYMD-1 is being developed to treat diseases and disorders marked by acute or chronic inflammation. The company’s second drug platform, Supera-CBD, is being developed to treat chronic pain, addiction, and epilepsy. The Supera-CBD is a novel synthetic derivative of cannabidiol (CBD) and is being developed to address and improve the growing CBD market, which includes FDA approved drugs and CBD products not regulated as drugs. TNF Pharmaceuticals, Inc. was formerly known as MyMD Pharmaceuticals, Inc. and changed its name to TNF Pharmaceuticals, Inc. in July 2024. The company was founded in 2014 and is headquartered in Baltimore, Maryland.